| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.28 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |